U.S. Physical Therapy, Inc. (USPH) Upgraded at Zacks Investment Research


Zacks Investment Research upgraded shares of U.S. Physical Therapy, Inc. (NYSE:USPH) from a sell rating to a hold rating in a research report sent to investors on Saturday.

According to Zacks, “U.S. Physical Therapy, Inc. operates outpatient physical and occupational therapy clinics which provide post-operative care and treatment for a variety of orthopedic-related disorders and sports-related injuries. “

USPH has been the subject of a number of other reports. Jefferies Group LLC set a $63.00 price target on U.S. Physical Therapy and gave the company a hold rating in a research report on Saturday, March 18th. Barrington Research downgraded U.S. Physical Therapy from an outperform rating to a market perform rating in a research report on Friday, March 17th.

Shares of U.S. Physical Therapy (NYSE:USPH) traded up 0.31% during midday trading on Friday, reaching $64.20. The company had a trading volume of 43,565 shares. U.S. Physical Therapy has a 12-month low of $48.71 and a 12-month high of $78.00. The stock has a market capitalization of $803.85 million, a PE ratio of 33.26 and a beta of 0.91. The stock’s 50 day moving average is $66.71 and its 200-day moving average is $66.88.

TRADEMARK VIOLATION NOTICE: This piece was posted by Markets Daily and is owned by of Markets Daily. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of international trademark and copyright law. The correct version of this piece can be accessed at https://www.themarketsdaily.com/2017/04/22/u-s-physical-therapy-inc-usph-upgraded-at-zacks-investment-research.html.

The company also recently announced a quarterly dividend, which will be paid on Friday, May 5th. Shareholders of record on Monday, April 17th will be given a $0.20 dividend. This is an increase from U.S. Physical Therapy’s previous quarterly dividend of $0.17. This represents a $0.80 dividend on an annualized basis and a yield of 1.25%. The ex-dividend date is Wednesday, April 12th. U.S. Physical Therapy’s dividend payout ratio (DPR) is currently 35.05%.

A number of hedge funds have recently added to or reduced their stakes in USPH. Sei Investments Co. increased its stake in U.S. Physical Therapy by 115.3% in the third quarter. Sei Investments Co. now owns 1,701 shares of the company’s stock worth $106,000 after buying an additional 911 shares in the last quarter. Acrospire Investment Management LLC increased its stake in U.S. Physical Therapy by 28.0% in the third quarter. Acrospire Investment Management LLC now owns 1,830 shares of the company’s stock worth $115,000 after buying an additional 400 shares in the last quarter. Catalyst Capital Advisors LLC purchased a new stake in U.S. Physical Therapy during the third quarter worth about $154,000. Tyers Asset Management LLC purchased a new stake in U.S. Physical Therapy during the fourth quarter worth about $166,000. Finally, Municipal Employees Retirement System of Michigan increased its stake in U.S. Physical Therapy by 1.5% in the third quarter. Municipal Employees Retirement System of Michigan now owns 2,770 shares of the company’s stock worth $174,000 after buying an additional 40 shares in the last quarter. 96.70% of the stock is owned by institutional investors and hedge funds.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

5 Day Chart for NYSE:USPH

Get a free copy of the Zacks research report on U.S. Physical Therapy (USPH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for U.S. Physical Therapy Inc. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for U.S. Physical Therapy Inc. and related companies with MarketBeat.com’s FREE daily email newsletter.



Source link

U.S. Physical Therapy, Inc. (USPH) Upgraded to “Hold” by Zacks Investment Research


Zacks Investment Research upgraded shares of U.S. Physical Therapy, Inc. (NYSE:USPH) from a sell rating to a hold rating in a research report report published on Saturday morning.

According to Zacks, “U.S. Physical Therapy, Inc. operates outpatient physical and occupational therapy clinics which provide post-operative care and treatment for a variety of orthopedic-related disorders and sports-related injuries. “

Several other research firms have also recently weighed in on USPH. Barrington Research cut U.S. Physical Therapy from an outperform rating to a market perform rating in a report on Friday, March 17th. Jefferies Group LLC set a $63.00 price target on U.S. Physical Therapy and gave the company a hold rating in a report on Saturday, March 18th.

U.S. Physical Therapy (NYSE:USPH) traded up 0.31% on Friday, reaching $64.20. The company’s stock had a trading volume of 43,565 shares. U.S. Physical Therapy has a one year low of $48.71 and a one year high of $78.00. The stock has a market cap of $803.85 million, a P/E ratio of 33.26 and a beta of 0.91. The stock has a 50-day moving average of $66.71 and a 200-day moving average of $66.88.

COPYRIGHT VIOLATION WARNING: “U.S. Physical Therapy, Inc. (USPH) Upgraded to “Hold” by Zacks Investment Research” was originally published by Markets Daily and is the property of of Markets Daily. If you are viewing this piece of content on another website, it was copied illegally and republished in violation of international copyright & trademark legislation. The original version of this piece of content can be accessed at https://www.themarketsdaily.com/2017/04/22/u-s-physical-therapy-inc-usph-upgraded-to-hold-by-zacks-investment-research.html.

The company also recently declared a quarterly dividend, which will be paid on Friday, May 5th. Shareholders of record on Monday, April 17th will be issued a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 1.25%. The ex-dividend date of this dividend is Wednesday, April 12th. This is a boost from U.S. Physical Therapy’s previous quarterly dividend of $0.17. U.S. Physical Therapy’s dividend payout ratio (DPR) is currently 35.05%.

Institutional investors have recently made changes to their positions in the company. Sei Investments Co. boosted its position in shares of U.S. Physical Therapy by 115.3% in the third quarter. Sei Investments Co. now owns 1,701 shares of the company’s stock worth $106,000 after buying an additional 911 shares during the period. Acrospire Investment Management LLC boosted its position in shares of U.S. Physical Therapy by 28.0% in the third quarter. Acrospire Investment Management LLC now owns 1,830 shares of the company’s stock worth $115,000 after buying an additional 400 shares during the period. Catalyst Capital Advisors LLC bought a new position in shares of U.S. Physical Therapy during the third quarter worth approximately $154,000. Tyers Asset Management LLC bought a new position in shares of U.S. Physical Therapy during the fourth quarter worth approximately $166,000. Finally, Municipal Employees Retirement System of Michigan boosted its position in shares of U.S. Physical Therapy by 1.5% in the third quarter. Municipal Employees Retirement System of Michigan now owns 2,770 shares of the company’s stock worth $174,000 after buying an additional 40 shares during the period. Hedge funds and other institutional investors own 96.70% of the company’s stock.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

5 Day Chart for NYSE:USPH



Source link

U.S. Physical Therapy, Inc. (USPH) Stock Rating Upgraded by Zacks Investment Research


Zacks Investment Research upgraded shares of U.S. Physical Therapy, Inc. (NYSE:USPH) from a sell rating to a hold rating in a research report sent to investors on Tuesday morning.

According to Zacks, “U.S. Physical Therapy, Inc. operates outpatient physical and occupational therapy clinics which provide post-operative care and treatment for a variety of orthopedic-related disorders and sports-related injuries. “

Other research analysts have also recently issued research reports about the company. Jefferies Group LLC set a $63.00 price target on U.S. Physical Therapy and gave the stock a hold rating in a research report on Saturday, March 18th. Barrington Research cut U.S. Physical Therapy from an outperform rating to a market perform rating in a research report on Friday, March 17th.

U.S. Physical Therapy (NYSE:USPH) opened at 64.00 on Tuesday. U.S. Physical Therapy has a 52 week low of $48.71 and a 52 week high of $78.00. The stock has a market cap of $801.34 million, a P/E ratio of 33.16 and a beta of 0.91. The stock has a 50 day moving average of $67.05 and a 200-day moving average of $66.87.

TRADEMARK VIOLATION WARNING: This report was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this report on another domain, it was illegally stolen and republished in violation of U.S. and international trademark & copyright legislation. The original version of this report can be accessed at https://www.thecerbatgem.com/2017/04/21/u-s-physical-therapy-inc-usph-lifted-to-hold-at-zacks-investment-research-updated.html.

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 5th. Shareholders of record on Monday, April 17th will be given a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 1.25%. The ex-dividend date is Wednesday, April 12th. This is a boost from U.S. Physical Therapy’s previous quarterly dividend of $0.17. U.S. Physical Therapy’s payout ratio is currently 35.05%.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. BlackRock Fund Advisors boosted its stake in U.S. Physical Therapy by 6.3% in the third quarter. BlackRock Fund Advisors now owns 927,868 shares of the company’s stock valued at $58,177,000 after buying an additional 54,747 shares during the period. Summit Global Investments purchased a new stake in U.S. Physical Therapy during the fourth quarter valued at $484,000. Schroder Investment Management Group boosted its stake in U.S. Physical Therapy by 209.2% in the third quarter. Schroder Investment Management Group now owns 319,373 shares of the company’s stock valued at $20,024,000 after buying an additional 216,073 shares during the period. Citadel Advisors LLC purchased a new stake in U.S. Physical Therapy during the third quarter valued at $530,000. Finally, Allianz Asset Management AG purchased a new stake in U.S. Physical Therapy during the fourth quarter valued at $381,000. Hedge funds and other institutional investors own 96.70% of the company’s stock.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

5 Day Chart for NYSE:USPH

Get a free copy of the Zacks research report on U.S. Physical Therapy (USPH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Stock Ratings for U.S. Physical Therapy Inc. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for U.S. Physical Therapy Inc. and related stocks with our FREE daily email newsletter.



Source link

U.S. Physical Therapy, Inc. (USPH) Downgraded to “Sell” at Zacks Investment Research


Zacks Investment Research lowered shares of U.S. Physical Therapy, Inc. (NYSE:USPH) from a hold rating to a sell rating in a research note published on Wednesday.

According to Zacks, “U.S. Physical Therapy, Inc. operates outpatient physical and occupational therapy clinics which provide post-operative care and treatment for a variety of orthopedic-related disorders and sports-related injuries. “

USPH has been the subject of a number of other research reports. Jefferies Group LLC set a $63.00 price target on shares of U.S. Physical Therapy and gave the stock a hold rating in a report on Saturday, March 18th. Barrington Research downgraded shares of U.S. Physical Therapy from an outperform rating to a market perform rating in a report on Friday, March 17th.

U.S. Physical Therapy (NYSE:USPH) traded up 0.08% during mid-day trading on Wednesday, hitting $63.55. The company had a trading volume of 64,329 shares. The firm’s 50 day moving average is $67.77 and its 200 day moving average is $66.92. The company has a market capitalization of $795.71 million, a price-to-earnings ratio of 32.93 and a beta of 0.91. U.S. Physical Therapy has a 52 week low of $48.10 and a 52 week high of $78.00.

ILLEGAL ACTIVITY WARNING: “U.S. Physical Therapy, Inc. (USPH) Downgraded to “Sell” at Zacks Investment Research” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this story on another site, it was copied illegally and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this story can be read at https://www.thecerbatgem.com/2017/04/19/u-s-physical-therapy-inc-usph-downgraded-by-zacks-investment-research-updated-updated.html.

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 5th. Shareholders of record on Monday, April 17th will be given a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 1.26%. The ex-dividend date is Wednesday, April 12th. This is a boost from U.S. Physical Therapy’s previous quarterly dividend of $0.17. U.S. Physical Therapy’s dividend payout ratio (DPR) is currently 35.05%.

A number of institutional investors have recently modified their holdings of USPH. Cue Financial Group Inc. acquired a new position in shares of U.S. Physical Therapy during the third quarter valued at approximately $492,000. Albert D Mason Inc. boosted its stake in U.S. Physical Therapy by 78.7% in the third quarter. Albert D Mason Inc. now owns 54,588 shares of the company’s stock valued at $3,423,000 after buying an additional 24,044 shares during the period. Great West Life Assurance Co. Can boosted its stake in U.S. Physical Therapy by 2.6% in the third quarter. Great West Life Assurance Co. Can now owns 17,993 shares of the company’s stock valued at $1,127,000 after buying an additional 450 shares during the period. Capital Fund Management S.A. purchased a new stake in U.S. Physical Therapy during the third quarter valued at about $445,000. Finally, Wells Fargo & Company MN boosted its stake in U.S. Physical Therapy by 3.3% in the third quarter. Wells Fargo & Company MN now owns 45,464 shares of the company’s stock valued at $2,851,000 after buying an additional 1,438 shares during the period. 96.70% of the stock is owned by institutional investors.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

5 Day Chart for NYSE:USPH

Get a free copy of the Zacks research report on U.S. Physical Therapy (USPH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Stock Ratings for U.S. Physical Therapy Inc. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for U.S. Physical Therapy Inc. and related stocks with our FREE daily email newsletter.



Source link

UM-Flint Physical Therapy Student Earns National Research Recognition


University of Michigan-Flint second-year physical therapy student Monica Godoshian was recently honored with a national award for her research related to balance and mobility in cancer patients. She was recognized by the American Physical Therapy Association (APTA) with the 2016 Oncology Section Student Research Award.

Godoshian has been working with a team of faculty, led by Dr. Min-Hui Huang, associate professor of physical therapy at UM-Flint.



Source link

Gloabl Home Physical Therapy Instrument Market Research Report 2016-2021


Global Home Physical Therapy Instrument Market by Manufacturers, Regions, Type and Application, Forecast to 2021.

Global Home Physical Therapy Instrument industry Report 2016 is a professional and in-depth research report on the world’s major regional Market conditions of the Global Home Physical Therapy Instrument industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China).

The Home Physical Therapy Instrument research report presents an in–depth analysis of the global market by growth, market segments and geographic markets. The review has been based on the report titled, ” Home Physical Therapy Instrument Market – Industry Analysis, Size, Share, Growth, Trends and Forecast, 2016 – 2021.”

For sample request click on http://www.marketresearchstore.com/report/global-home-physical-therapy-instrument-market-report-2016-94558#RequestSample

Firstly, Home Physical Therapy Instrument Report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The market analysis is provided for the international market including development history, competitive landscape analysis, and major region’s development status.

This research report incorporates an in-depth analysis of the R&D technologies, including market estimations and trends through 2016. Major players, competitive intelligence, innovative technologies, market dynamics and geographic opportunities are discussed in detail in the report. The report also examines recent developments and product portfolios of the major players along with their market shares.

Have Any Query? Ask Our Expert @ http://www.marketresearchstore.com/report/global-home-physical-therapy-instrument-market-report-2016-94558#InquiryForBuying

The report includes Profiles of the manufacturers of the leading products are analyzed, their specific product strategies are outlined, and their pipeline of products is discussed. Market figures are based on cost,price,revenues,growth rate and import/export in the current worldwide Home Physical Therapy Instrument industry.

The report is arranged to provide an overview of the Home Physical Therapy Instrument industry by product, company and geography. Forecasts are broken down by geographic region or by country. The worldwide market is analyzed and data provided for each disease sub-segment.



Source link

Physical therapy and rehabilitation research – looking forward


Almost everyone has been treated—or knows someone who has been treated—by a physical therapist. The field of physical therapy encompasses not only rehabilitation after injury and surgery but also a wide range of preventive health services and vital lines of research. Dr. Alan Jette, PT, PhD, Editor-in-Chief of Physical Therapy (PTJ), the scientific journal of the American Physical Therapy Association, shares his vision for PTJ and his take on opportunities and challenges for the physical therapy profession.

 What led you to the field of physical therapy?

Like many, my first exposure to physical therapy was as a patient. As an 11-year-old boy, I fell from a high tree house and fractured my right femur and both wrists. After weeks in traction, I needed considerable rehabilitation to help in my recovery. Subsequently, as an undergraduate student in western New York, I worked as an orderly in a local nursing home and rehabilitation center where I was first introduced to the emerging field of geriatric rehabilitation. That experience led me to change my major from sociology to physical therapy.

How and when did you get involved with Physical Therapy (PTJ)?

Dr. Jules Rothstein, former editor-in-chief of PTJ, first encouraged me to get involved in PTJ. At the time, we were both fellows of the rheumatology association and doing similar research in scientific measurement. Through his encouragement and support, I served on the PTJ editorial board from 1990–1996 and as deputy editor from 1993–1996. I also served as acting editor-in-chief of PTJ in 2005 after the untimely passing of Dr. Rothstein. Involvement with PTJ has been the major way in which I have tried to give back to the profession of physical therapy.

Describe what you think PTJ will look like in 20 years and the type of articles it will publish.

physical-therapy-1698817_1280
Physical therapy by hamiltonpaviana. CC0 public domain via Pixabay.

I see PTJ becoming the top international rehabilitation science journal that focuses not only on publishing the best in rehabilitation science, but on using various forms of social media to help move new evidence into rehabilitation practice worldwide.

What is the most important issue in the field of physical therapy right now? 

In my opinion, in the United States, the major challenge for the profession is to expand its role as a key member of the health care team. Fulfilling our potential there will be difficult without also overcoming other significant challenges, such as patient access barriers and narrow and restrictive payment policies.

Are there any areas you think are overlooked?

Due to payment barriers, physical therapists are not involved enough in population health and prevention of disease and disability.

How would you describe PTJ in three words?

Science, Scholarship, Global.

Tell us about your work outside the journal.

The focus of my research is on the science around disability: its definition, measurement, epidemiology, prevention, and treatment. As a physical therapist who is a professor of health policy and management in a school of public health, I work on the boundary between population health and rehabilitation. My current research involves preventing disability among adults with spinal cord injury, helping create a center devoted to active aging, and implementing a major project aimed at helping the US Social Security Administration develop and use standardized approaches to examine human functioning that relates to an individual’s ability to work. Each year, I teach a doctoral level course on scientific measurement at the MGH Institute of Health Professions in Boston. I also serve on several panels of the National Academy of Medicine related to disability and population science and policy.

Feature image credit: “Senior Male Patient Working With Physiotherapist In Hospital” by monkeybusinessimages via iStockphoto.



Source link

U.S. Physical Therapy, Inc. (USPH) Downgraded to Hold at Zacks Investment Research


U.S. Physical Therapy, Inc. (NYSE:USPH) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Thursday.

According to Zacks, “U.S. Physical Therapy, Inc. operates outpatient physical and occupational therapy clinics which provide post-operative care and treatment for a variety of orthopedic-related disorders and sports-related injuries. “

Several other equities analysts have also recently issued reports on the company. Jefferies Group LLC reissued a “hold” rating and set a $63.00 target price (up from $60.00) on shares of U.S. Physical Therapy in a research note on Monday, December 5th. JMP Securities reissued a “hold” rating on shares of U.S. Physical Therapy in a research note on Monday, November 7th. Finally, Barrington Research raised U.S. Physical Therapy from a “market perform” rating to an “outperform” rating and set a $61.00 target price on the stock in a research note on Friday, November 4th.

U.S. Physical Therapy (NYSE:USPH) opened at 70.00 on Thursday. The firm has a 50-day moving average of $70.34 and a 200-day moving average of $63.89. The company has a market cap of $876.47 million, a price-to-earnings ratio of 36.27 and a beta of 0.91. U.S. Physical Therapy has a 52 week low of $45.76 and a 52 week high of $73.05.

COPYRIGHT VIOLATION NOTICE: This report was posted by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this report on another domain, it was copied illegally and republished in violation of United States & international copyright law. The correct version of this report can be read at https://sportsperspectives.com/2017/02/02/u-s-physical-therapy-inc-usph-downgraded-to-hold-at-zacks-investment-research.html.

In other U.S. Physical Therapy news, CFO Lawrance W. Mcafee sold 2,000 shares of the business’s stock in a transaction on Thursday, November 10th. The stock was sold at an average price of $58.04, for a total value of $116,080.00. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Edward L. Kuntz sold 2,500 shares of the business’s stock in a transaction on Friday, December 9th. The stock was sold at an average price of $68.40, for a total value of $171,000.00. The disclosure for this sale can be found here. Insiders have sold 10,547 shares of company stock worth $659,654 over the last 90 days. 4.30% of the stock is currently owned by corporate insiders.

A number of large investors have recently added to or reduced their stakes in the company. Schroder Investment Management Group increased its stake in U.S. Physical Therapy by 209.2% in the third quarter. Schroder Investment Management Group now owns 319,373 shares of the company’s stock valued at $20,024,000 after buying an additional 216,073 shares during the period. Neuberger Berman Group LLC increased its stake in U.S. Physical Therapy by 24.6% in the second quarter. Neuberger Berman Group LLC now owns 947,897 shares of the company’s stock valued at $57,073,000 after buying an additional 187,395 shares during the period. Aberdeen Asset Management PLC UK increased its stake in U.S. Physical Therapy by 65.3% in the second quarter. Aberdeen Asset Management PLC UK now owns 321,707 shares of the company’s stock valued at $19,370,000 after buying an additional 127,094 shares during the period. Weatherbie Capital LLC increased its stake in U.S. Physical Therapy by 376.8% in the second quarter. Weatherbie Capital LLC now owns 91,110 shares of the company’s stock valued at $5,486,000 after buying an additional 72,000 shares during the period. Finally, Russell Investments Group Ltd. bought a new stake in U.S. Physical Therapy during the fourth quarter valued at approximately $4,733,000. 97.44% of the stock is currently owned by institutional investors and hedge funds.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

5 Day Chart for NYSE:USPH

Receive News & Ratings for U.S. Physical Therapy Inc. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for U.S. Physical Therapy Inc. and related companies with MarketBeat.com’s FREE daily email newsletter.



Source link